Madrigal Pharmaceuticals Inc.
MDGL | NASDAQ
$430.36
-$1.34 (-0.31%)
At close: Oct 30, 2026, 4:00 PM ET
$429.15
-$1.21 (-0.28%)
Pre-market:
Nov 2, 2026, 4:13 AM ET
Market Data
Market Cap $9.94B
Enterprise Value $9.45B
Beta -1.05
Average Volume 321.73K
Shares Outstanding (Diluted) 29.15M
Shares Change YoY 31.24%
Institutional Ownership 81.57%
Exchange NASDAQ
ISIN US5588681057
Price Performance
Price Change 1M -14.6%
Price Change 3M -7.9%
Price Change 6M -16.2%
Price Change YTD -26.1%
Price Change 1Y 2.7%
Price Change 3Y 227.6%
Price Change 5Y 453.5%
1M CAGR (ann.) -19.0%
1Y CAGR (ann.) 2.1%
5Y CAGR (ann.) 40.6%
All-Time CAGR 39.2%
Valuation
PE Ratio -33.39
Forward PE 153.67
PEG Ratio 96.72
Forward PEG 0.73
PS Ratio 7.74
Forward PS 4.70
PB Ratio 18.99
P/FCF Ratio -48.20
P/Adj. FCF Ratio -32.93
P/OCF Ratio -63.47
EV/Sales 7.36
EV/EBIT -31.52
EV/EBITDA -31.64
EV/FCF -45.82
Earnings Yield -3.0%
FCF Yield -2.1%
Adj. FCF Yield -3.0%
Financial Health
Net Cash $496.93M
Total Debt $347.75M
Cash & Short-Term Investments $838.75M
Total Assets $1.24B
Current Ratio 3.20
Quick Ratio 2.94
Debt / Equity Ratio 0.66
Debt / EBITDA -1.16
Debt / FCF -1.69
OCF / Debt -0.57
Interest Coverage -10.24
Altman Z-Score 6.78
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 91.5%
Operating Profit Margin -25.1%
EBITDA Margin -22.8%
Net Profit Margin -25.3%
FCF Margin -16.1%
Adj. FCF Margin -23.5%
SBC / Revenue 7.5%
SBC Impact (per share) -46.4%
Returns
Return on Assets -26.1%
Return on Equity -56.6%
Return on Invested Capital -37.0%
Return on Capital Employed -37.1%
Return on Tangible Assets -26.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 105.0%
Revenue CAGR 5Y 85.0%
Revenue CAGR 10Y 50.9%
EPS CAGR 3Y 36.9%
EPS CAGR 5Y 6.0%
EPS CAGR 10Y -15.4%
FCF CAGR 3Y 38.6%
FCF CAGR 5Y -1.4%
FCF CAGR 10Y -22.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y 131.5%
Revenue Growth Next 3Y 43.3%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$0.86
EPS Growth Est (next Q) -83.0%
Revenue Est (next Q) $404.17M
Revenue Growth Est (next Q) 40.7%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $684.80
Price Target Upside 59.1%
Cash Flow
Operating Cash Flow $-197.72M
Free Cash Flow $-206.29M
Adj. Free Cash Flow $-301.93M
FCF Per Share -$7.08
OCF Per Share -$6.78
OCF/S Ratio -15.4%
Income Statement
Revenue $1.28B
Gross Profit $1.17B
Operating Income $-322.62M
EBITDA $-298.76M
Net Income $-325.1M
EPS (Diluted) -$12.89
Revenue / Employee $1.4M
Profit / Employee $-355.3K
Employees 915
Add to Watchlist
Select watchlists to add or remove MDGL